Cutting-edge life science company offers high upside cannabis medical product potential. The company aims to disrupt the drug development market by developing evidence-based cannabis products to help combat serious medical conditions
FREE
Only logged in users are allowed to post comments. Register/ Log in
The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2021 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted.
Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any
a state-approved cannabis cultivation license for its 30,000 square-foot facility in Stockton, California.
The California-based company was given a “green light” from CalCannabis Cultivation Licensing, a division of the California Department of Food and Agriculture known for securing public and environmental safety through the licensing.
Juva Life now plans to activate its facility through the cultivation of around 8,000 square feet of flowering canopy and around 5,000 square feet of non-flowering canopy.
Roughly 4,500 square feet will be added for dry storage, pre-roll, trim, breeding, and environmental system areas. Up to 3,000 square feet of space will be used as a delivery, packaging and distribution center. Once all these areas reach their full capacity, the facility should be able to generate around 6,000 pounds of cannabis flower.
The Next Marijuana Boom Could Be Even Bigger Than The Last
Published: January 18, 2021
That’s because, despite “Big Pharma’s” massive resources and staggering amounts of spending,
no large pharmaceutical company has ever been able to solve the industry’s most critical problem.
Drug development for major pharmaceutical companies can take as long as a decade.and cost hundreds of billions of dollars in research and development.
Yet a small, little-known company – which could become a truly disruptive cannabis player – now appears uniquely positioned to
upend the drug development market by developing evidence-based cannabis products to combat many of the world’s most serious medical conditions.